Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro

British Journal of Pharmacology

Volumn 150, Issue 4, 2007, Pages 455-462

  Jarvie, E M ^a   North Laidler, V J ^a   Corcoran, S ^a   Bassil, A ^a   Sanger, G J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 HT 4; Erythromycin; Motilin; Prokinetic; Rabbit; Stomach; Tegaserod

Indexed keywords

8 AMINO 7 CHLORO 1,4 BENZODIOXAN 5 CARBOXYLIC ACID 1 BUTYL 4 PIPERIDINYLMETHYL ESTER; AMASTATIN; BESTATIN; CARBACHOL; ERYTHROMYCIN; MOTILIN; PHOSPHORAMIDON; PROKINETIC AGENT; SEROTONIN 4 AGONIST; TEGASEROD;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; ELECTROSTIMULATION; IN VITRO STUDY; MALE; MUSCLE CONTRACTION; MUSCLE EXCITATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; STOMACH MOTILITY;

ANIMALS; CARBACHOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ERYTHROMYCIN; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; HALF-LIFE; INDOLES; LIGANDS; MALE; MANOMETRY; MOTILIN; MUSCARINIC AGONISTS; RABBITS; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, NEUROPEPTIDE; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN AGONISTS; STIMULATION, CHEMICAL;

EID: 33847153056     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707118     Document Type: Article

References (44)

1. Aerssens J, Depoortere I, Thielemans L, Mitselos A, Coulie B, Peeters TL (2004). The rat lacks functional genes for motilin and for the motilin receptor. Neurogastroenterol Motil 16: 841.
2. Annese V, Lombardi G, Frusciante V, Germani U, Andriulli A, Bassotti G (1997). Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. Aliment Pharmacol Ther 11: 599-603.
3. Bassil AK, Dass NB, Murray CD, Muir AI, Sanger GJ (2005). Prokineticin-2, motilin, ghrelin and metoclopramide: Prokinetic activity in mouse stomach and colon. Eur J Pharmacol 524: 138-144.
4. 2B receptor antagonist in vitro and in vivo. Br J Pharmacol 143: 549-560.
5. Boivin MA, Carey MC, Levy H (2003). Erythromycin accelerates gastric emptying in a dose-response manner in healthy subjects. Pharmacotherapy 23: 5-8.
6. 4 receptor. J Pharm Exp Ther 252: 1378-1386.
7. 4 receptors in rabbit isolated gastric antrum. Proc Br Pharmacol Soc at http://www.pa2online.org/Vol1Issue4abst157P.html.
8. Coulie B, Tack J, Peeters T, Janssens J (1998). Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut 43: 395-400.
9. Cowles VE, Nellans HN, Seifert TR, Besecke LM, Segreti JA, Mohning KM et al. (2000). Effect of novel motilide ABT-229 versus erythromycin and cisapride on gastric emptying in dogs. J Pharmacol Exp Ther 293: 1106-1111.
10. Dass NB, Hill J, Muir A, Testa T, Wise A, Sanger GJ (2003). The rabbit motilin receptor: molecular characterisation and pharmacology. Br J Pharmacol 140: 948-954.
11. Depoortere I, Peeters TL (1997). Inhibitory effect of motilides at high concentrations are not mediated via motilin receptors, but via calcium channels. Gastroenterology 111: A721.
12. Depoortere I, Thijs T, Thielemans L, Robberecht P, Peeters TL (2003). Interaction of the growth hormone-releasing peptides ghrelin and growth hormone-releasing peptide-6 with the motilin receptor in the rabbit gastric antrum. J Pharmacol Exp Ther 305: 660-667.
13. Dhir R, Richter JE (2004). Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis. J Clin Gastroenterol 38: 237-242.
14. Dibaise JK, Quigley EM (1999). Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one centre's experience. J Clin Gastroenterol 28: 131-134.
15. Erbas T, Varoglu E, Erbas B, Tastekin G, Akalin S (1993). Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis. Diabetes Care 16: 1511-1514.
16. Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong S-S et al. (1999). Receptor for motilin identified in the human gastrointestinal system. Science 284: 2184-2188.
17. Furness JB, Clark MJ, Wright T, Bertrand PP, Bornstein JC, Verlinden M (1999). An action of erythromycin in the intestine that is not mediated via motilin receptors. Clin Exp Pharmacol Physiol 26: 100-104.
18. Hill J, Szekeres P, Muir A, Sanger GJ (2002). Molecular, functional and cross-species comparisons between the receptors for the prokinetic neuropeptides, motilin and ghrelin. Gastroenterology 122 (Suppl 1): A54.
19. Hunter A, Regnard C, Armstrong C (2005). The use of long-term, low-dose erythromycin in treating persistent gastric stasis. J Pain Symptom Management 29: 430-433.
20. 13 motilin (KW-5139)-evoked release of acetylcholine from enteric neurones in the rabbit duodenum. Br J Pharmacol 109: 94-99.
21. Lamian V, Rich A, Ma Z, Li J, Seethala R, Gordon D et al. (2006). Characterization of agonist-induced motilin receptor trafficking and its implications for tachyphylaxis. Mol Pharmacol 69: 109-118.
22. 4 receptor ligands: applications and new prospects. J Med Chem 46: 319-344.
23. Matsuura B, Dong M, Miller LJ (2002). Differential determinants for peptide and non-peptidyl ligand binding to the motilin receptor. Critical role of second extracellular loop for peptide binding and action. J Biol Chem 277: 9834-9839.
24. Minocha A, Galligan JJ (1991). Erythromycin inhibits contractions of nerve-muscle preparations of the guinea-pig small intestine. J Pharmacol Exp Ther 257: 1248-1252.
25. 13]motilin in E.coli. Biotech Lett 10: 763-768.
26. Nissan A, Freund HR, Hanani M (2002). Direct inhibitory effect of erythromycin on human alimentary tract smooth muscle. Am J Surg 183: 413-418.
27. Park M-I, Ferber I, Camilleri M, Allenby K, Trillo R, Burton D et al. (2006). Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomised, placebo-controlled study. Neurogastroenterol Motil 18: 28-36.
28. Peeters TL (1999). Potential of motilides in the treatment of hypomotility syndromes. In: Herbert MK, Holzer P, Roewer N (eds). Problems of the Gastrointestinal Tract in Anaesthesia. Springer-Verlag: Berlin, Heidelberg, pp 39-51.
29. Peeters T, Bormans V, Matthijs G, Vantrappen G (1986). Comparison of the biological activity of canine and porcine motilin in rabbit. Regul Pept 15: 333-339.
30. Quigley EM (2000). Pharmacotherapy of gastroparesis. Exp Opin Pharmacotherapy 1: 881-887.
31. Richards RD, Davenport K, Mccallum RW (1993). The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 88: 203-207.
32. Sanger GJ (1985a). Effects of metoclopramide and domperidone on cholinergically -mediated contractions of human isolated stomach muscle. J Pharm Pharmacol 37: 661-664.
33. Sanger GJ (1985b). The effects of various pharmacological agents on the metoclopramide-induced increase in cholinergic-mediated contractions of rat isolated forestomach. Eur J Pharmacol 114: 139-145.
34. Sanger GJ (1987). Activation by metoclopramide of a myenteric 5-hydroxytryptamine-like receptor. J Pharm Pharmacol 39: 449-453.
35. 4 receptor agonists and antagonists. In: Eglen RM (ed). 5-HT4 Receptors in the Brain and Periphery. Springer-Verlag; Berlin,pp 213-226.
36. Scott LJ, Perry cm (1999). Tegaserod. Drugs 58: 491-496.
37. Sturm A, Holtmann G, Goebell H, Gerken G (1999). Prokinetics in patients with gastroparesis: a systematic analysis. Digestion 60: 422-427.
38. Tack j. (1995). Motilin and the enteric nervous system in the control of interdigestive and postprandial gastric motility. Acta Gastroenterologica Belgica 58: 21-30.
39. Thielemans L, Depoortere I, Perret J, Robberecht P, Liu Y, Thijs T et al (2005). Desensitization of the human motilin receptor by motilides. J Pharmacol Exp Ther 313: 1397-1405.
40. Tonini M, Candura SM, Onori L, Coccini T, Manzo L, Rizzi CA (1992). 5-Hydroxytryptamine4 receptor agonists facilitate cholinergic transmission in the circular muscle of guinea-pig ileum: antagonism by tropisetron and DAU 6285. Life Sci 50: 173-178.
41. 13]motilin in the isolated rabbit gastric antrum. Eur J Pharmacol 337: 267-274.
42. 4 receptor antagonist, on guinea-pig distal colon. Br J Pharmacol 112: 789-794.
43. Xu L, Depoortere I, Vertongen P, Waelbroeck M, Robberecht P, Peeters TL (2005). Motilin and erythromycin-A share a common binding site in the third transmembrane segment of the motilin receptor. Biochem Pharmacol 70: 879-887.
44. Zatman TF, Hall JE, Harmer M (2001). Gastric residual volume in children: a study comparing efficiency of erythromycin and metoclopramide as prokinetic agents. Br J Anaesthesia 86: 869-871.